Skip to main content

Par 604 (Lamotrigine Extended-Release 250 mg)

Pill with imprint Par 604 is White, Round and has been identified as Lamotrigine Extended-Release 250 mg. It is supplied by Par Pharmaceutical Inc.

Lamotrigine is used in the treatment of bipolar disorder; schizoaffective disorder; seizure prevention; epilepsy and belongs to the drug class triazine anticonvulsants. Risk cannot be ruled out during pregnancy. Lamotrigine 250 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for Par 604

Lamotrigine extended-release 250 mg Par 604

Lamotrigine Extended-Release

Par 604
250 mg
Prescription only
Drug Class
Triazine anticonvulsants
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Par Pharmaceutical Inc.
National Drug Code (NDC)
Inactive Ingredients
methacrylic acid, hypromelloses, silicon dioxide

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.